Dynamic and regulated association of caveolin with lipid bodies: Modulation of lipid body motility and function by a dominant negative mutant by Pol, Albert et al.
Molecular Biology of the Cell
Vol. 15, 99–110, January 2004
Dynamic and Regulated Association of Caveolin with
Lipid Bodies: Modulation of Lipid Body Motility and
Function by a Dominant Negative Mutant□V
Albert Pol,*† Sally Martin,* Manuel A. Fernandez,† Charles Ferguson,*
Amanda Carozzi,* Robert Luetterforst*, Carlos Enrich,† and
Robert G. Parton*‡
*Institute for Molecular Bioscience, Centre for Microscopy and Microanalysis, and School of
Biomedical Sciences, University of Queensland, Queensland 4072, Australia; and †Departament de
Biologia Cellular, Institut d’Investigacions Biome`diques August Pi i Sunyer (IDIBAPS), Facultat de
Medicina, Universitat de Barcelona, Barcelona 08036, Spain
Submitted June 6, 2003; Revised July 18, 2003; Accepted September 3, 2003
Monitoring Editor: Jean Gruenberg
Caveolins are a crucial component of caveolae but have also been localized to the Golgi complex, and, under some
experimental conditions, to lipid bodies (LBs). The physiological relevance and dynamics of LB association remain
unclear. We now show that endogenous caveolin-1 and caveolin-2 redistribute to LBs in lipid loaded A431 and FRT cells.
Association with LBs is regulated and reversible; removal of fatty acids causes caveolin to rapidly leave the lipid body.
We also show by subcellular fractionation, light and electron microscopy that during the first hours of liver regeneration,
caveolins show a dramatic redistribution from the cell surface to the newly formed LBs. At later stages of the regeneration
process (when LBs are still abundant), the levels of caveolins in LBs decrease dramatically. As a model system to study
association of caveolins with LBs we have used brefeldin A (BFA). BFA causes rapid redistribution of endogenous
caveolins to LBs and this association was reversed upon BFA washout. Finally, we have used a dominant negative
LB-associated caveolin mutant (cavDGV) to study LB formation and to examine its effect on LB function. We now show that
the cavDGV mutant inhibits microtubule-dependent LB motility and blocks the reversal of lipid accumulation in LBs.
INTRODUCTION
Recent studies have reported the presence of caveolins on
the surface of intracellular lipid bodies (LBs; Fujimoto et al.,
2001; Ostermeyer et al., 2001; Pol et al., 2001). Although LBs
are common organelles in the cytoplasm of eukaryotic cells,
very little is known about their composition or physiological
role (see Londos et al., 1999; Brown, 2001; van Meer, 2001 for
a review). Lipid bodies consist of a core of apolar lipids (as
triacylglycerol or cholesterol esters) encapsulated by a single
monolayer of phospholipids (Tauchi-Sato et al., 2002). Al-
though LB biogenesis is not well understood, it is assumed
that the LBs form within the two leaflets of the ER mem-
brane to function as lipid storage sites.
To date, a very limited group of proteins have been shown
to associate with LBs; perilipins in adipocytes and steroido-
genic tissues (Greenberg et al., 1991), adipophilin in most
mammalian cells (Heid et al., 1998), oleosins in plants (Qu
and Huang, 1990), eicosanoid synthesizing enzymes in var-
ious types of cells (Weller and Dvorak, 1994), vimentin
(Franke et al., 1987), “capsular proteins” in adrenal cells
(Wang and Fong, 1995), and more recently, caveolins (Fuji-
moto et al., 2001; Ostermeyer et al., 2001; Pol et al., 2001).
Although the LB targeting domain of some of these proteins
has been examined, a consensus sequence or molecular de-
terminant involved in LB association has not been described.
Caveolins represent an intriguing system to study how
membrane components can associate with LBs. Fujimoto
and colleagues (Fujimoto et al., 2001) demonstrated that
overexpressed caveolin-2 can be partially targeted to LBs. In
addition, Ostermeyer et al. (2001) showed that caveolin-1
accumulates in LBs when it is linked to an ER-retrieval
sequence (cav-KKSL). These studies also demonstrated that
caveolins can be artificially directed into LBs when the func-
tional integrity of the Golgi complex is disrupted by means
of brefeldin A (BFA). It was suggested that the presence of
caveolin in LBs is more artifactual than physiological, a
consequence of the accumulation of high levels of caveolins
in the ER. This was supported by the fact that endogenous
caveolins were not detected on the LBs and because the
transfected caveolins could not exit the LBs when cells were
allowed to recover BFA. Using a different strategy, we have
previously demonstrated (Pol et al., 2001) that a mutant
caveolin protein (cav3DGV) that acts as a dominant negative
for caveolin function accumulates irreversibly in the LBs.
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The fact that this mutant causes an intracellular cholesterol
imbalance suggested a possible role for caveolin in intracel-
lular lipid transport from these organelles (Pol et al., 2001;
van Meer, 2001). Although caveolin is an integral membrane
“hairpin”-like protein, it has also been suggested that caveo-
lin may function without being integrated in a membrane
(Uittenbogaard et al., 1998, 2002). Whether a cytosolic inter-
mediate could be involved in trafficking to lipid bodies
remains unknown. It has been postulated that because
caveolins have a single central hydrophobic domain similar
to oleosins this hydrophobic domain may interact with the
core of neutral lipids in the LBs.
In the present study, we have addressed whether caveo-
lins associate with LBs under physiological conditions and,
if so, whether this is a regulated process. We demonstrate
that endogenous caveolins can move in and out of the LB, in
a bidirectional process, suggesting that specific retrieval
mechanisms must exist. We also prove that endogenous
caveolin moves to the LBs not only after disrupting the Golgi
membranes with BFA, but also in response to the intracel-
lular accumulation of lipids. In regenerating liver caveolin
relocates from the plasma membrane to newly formed LBs,
suggesting a role for caveolin in lipid transport to or from
the LBs. Finally, we have investigated the effect of a caveolin
dominant negative mutant on LB function and show that
specific effects on LBs can underlie the perturbation of lipid
regulation and signal transduction at the cell surface.
MATERIALS AND METHODS
Plasmids, Antibodies, and Reagents
YFP-tagged full-length cav3 and YFP-tagged and GFP-tagged cav3DGV were
generated following the method described previously (Luetterforst et al.,
1999). Primary antibodies and their abbreviations used in this work are
summarized in Table 1. Gold-conjugated protein A was purchased from the
University of Utrecht, Utrecht, The Netherlands. Fluorescein, Cy3, and gold-
conjugated secondary antibodies were from Jackson ImmunoResearch (West
Grove, PA). HRP-conjugated secondary antibodies were from Zymed Labo-
ratories (South San Francisco, CA). BFA), cycloheximide (CyHx), oil red, and
nocodazole were purchased from Sigma Chemical Co. (St. Louis, MO) 4,6-
diamidino-2-phenylindole dihydrochloride (DAPI) and Nile red were from
Molecular Probes (Eugene, OR). Oleic acid (OlAc) and fatty acid free BSA
were from Calbiochem (La Jolla, CA).
Cell Culture
Baby hamster kidney cells (BHK), Fisher rat thyroid cells (FRT), Vero cells,
and A431 cells were maintained in DMEM with 10% vol/vol serum supreme
(SS; Biowhitaker, Walkersville, MD) supplemented with 2 mM l-glutamine,
penicillin (50 U/ml), and streptomycin sulfate (50 g/ml) and in some
experiments supplemented with 50 g/ml oleic acid and free fatty acid BSA.
Cells were split the day before the experiment or transfection. Cells were
transfected using Lipofectamine plus (Invitrogen, San Diego, CA) as outlined
previously (Pol et al., 2001).
Immunofluorescence Microscopy, Electron Microscopy,
and Time-Lapse Video Microscopy
Immunofluorescence, videomicroscopy and immunoelectron microscopy on
frozen sections was performed as described previously (Pol et al., 2001). Nile
red was diluted in the mounting mowiol (1/1000 from a stock saturated
solution in acetone) and for cells were fixed in PFA for oil red cells were
incubated 1 min on ice cold (a saturated and filtered stock solution in 50%
Isopropanol). Immunolabeling of fractions was performed by mixing frac-
tions in a 1:1 vol/vol ratio with 8% PFA in PBS at room temperature and
applied to polylysine-coated grids. The grids were then washed with PBS,
labeled, and embedded in methylcellulose/uranyl acetate as for frozen sec-
tions. For quantitation of LB motility, cells were transfected with cav3DGV-
YFP or caveolin-3-YFP. After 24 h, expressing cells were identified by fluo-
rescence microscopy, and LB motility in those cells was assessed under bright
field illumination. To track the movement of individual LBs a composite was
made in Photoshop (Adobe Systems, San Jose, CA) from three images taken
at intervals of 10 s (with each image colored differently). The total distance
moved was then measured in NIH image (Bethesda, MD).
Cell Fractionation and Western Blot
Confluent 10-cm dishes of BHK cells were washed twice with cold PBS before
being scraped into ice-cold 10 mM Tris, pH 7.5, 150 mM NaCl, 5 mM EDTA,
and a mixture of protease and phosphatase inhibitors. Cells were homoge-
nized by gentle sonication for 10 s on ice and by passage through a 22-gauge
needle 10 times at 4°C. Nuclei and unbroken cells were removed by centrif-
ugation at 5000 rpm for 5 min at 4°C in a TLS-55 rotor (Beckman, Fullerton,
CA). The resulting supernatant was mixed with the same volume of 2.5 M
sucrose and loaded at the bottom of a discontinuous sucrose gradient com-
posed by seven phases ranging from 5 to 35% (wt/vol) sucrose. The tubes
were centrifuged at 50,000 rpm for 4 h at 4°C in a TLS-55 rotor (Beckman).
Finally, 14 aliquots were unloaded from the top of the gradient and stored at
20°C. When the isolated fractions were analyzed for electron microscopy,
the top fraction of the gradient (fraction 1) was processed immediately. For
Western blotting analysis with a polyclonal anticaveolin antibody (rbTL),
equal volumes of each aliquot were electrophoretically separated by SDS-
PAGE in 12% polyacrylamide gels as described previously (Pol et al., 2001).
The quantification of Western blots was calculated densitometrically with the
Bio-Image (Millipore, Bedford, MA) program that reads and calculates the
band intensity and the band area. In Figures 2, B and F, and 4B, the results are
expressed as percentages of every band compared with the total integrated
intensity. In Figure 4, E–G, the results are expressed as percentages of every
band compared with the integrated intensity corresponding to the first lane of
the blot. Only bands in the same gel were compared, but the final percentage
corresponds to the mean of at least three different experiments.
Liver Regeneration Studies
Male Sprague Dawley rats weighing 200–220 g were used for all experiments.
Animals were kept under a controlled lighting schedule with a 12-h dark
period. All animals received human care in compliance with institutional
guidelines regulated by the European Community. Food and water were
available ad libitum but rats were fasted overnight before experiments. Partial
hepatectomies (PHs) were carried out according the procedure of Higgins and
Anderson (1931), in which 66% (medial and left lateral lobes) of liver mass is
removed under Fluorane anesthesia. Hepatocytes were isolated and cultured
from a young male Sprague Dawley rat using a sterile method (Bissell et al.,
1973) as described previously (Calvo et al., 2001). Crude membranes, endo-
somes, and CEF were obtained as described previously (Pol et al., 1999).
RESULTS
Endogenous Caveolins Associate with Lipid Bodies:
Identification of Caveolins on LBs in Lipid-loaded A431
and FRT Cells
The visualization of overexpressed caveolins and mutant
caveolins associated with LBs suggest that caveolins have
some propensity to associate with LBs. However, endoge-
nous caveolins have not been observed in LBs in the absence
Table 1. Antibodies used in this work
Antibody Abbreviation Reference
Monoclonal mouse anti–caveolin-1 moZy Zymed Labs. 03-6000
Monoclonal mouse anti–caveolin-1 moTL Transduction Labs. C13620
Monoclonal mouse anti–caveolin-2 TLcav2 Transduction Labs. C57820
Rabbit polyclonal anti-caveolin (N-terminal domain) rbTL Transduction Labs. C13630
Rabbit affinity purified anti-caveolin (caveolin identity domain) Con-cav Luetterforst et al. (1999)
Monoclonal mouse anti-GM130 GM130 Transduction Labs. G65120
Monoclonal mouse anti-adipophilin Adipophilin Progen 651102
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of BFA and the trafficking pathways to and from LBs have
not been defined. We investigated whether endogenous
caveolins could associate with LBs under physiological con-
ditions and specifically whether this might occur in response
to lipid loading of cells. We therefore investigated whether
caveolins associate with LBs in A431 cells and FRT cells
grown in the presence of elevated levels of the free fatty
acid, oleic acid.
A431 cells have abundant caveolae (Parton, 1994) and
show strong staining for caveolin-1 (rbTL) in the Golgi com-
plex and at the cell surface (Figure 1A). In contrast, caveo-
lin-2 (TLcav2) only shows labeling in the Golgi complex in
these cells (arrows, Figure 1B). Treatment of cells for 24 h
with oleic acid (OlAc) caused redistribution of caveolins 1
and 2 to ring-shaped cytoplasmic structures (arrowheads,
Figure 1, C and D) identified as LBs by the colocalization
with the neutral lipid stain, Nile red (Figure 1G). Association
of caveolins with the LBs was accompanied by an apparent
decrease in staining at the PM for caveolin-1 and partial loss
of Golgi staining for caveolin-2. FRT cells lack caveolin-1 but
show strong Golgi labeling for caveolin-2 (TLcav2; arrows,
Figure 1H). We investigated whether in the absence of
caveolin-1, caveolin-2 could redistribute to LBs. As shown in
Figure 1I, treatment of cells with OlAc caused almost com-
plete redistribution of caveolin-2 from the Golgi complex to
LBs, which colabeled for Nile red (Figure 1N).
To investigate the reversibility of the association of caveo-
lins with the LBs, OlAc was subsequently removed from the
culture medium. Caveolin-1 and -2 in A431 cells (unpub-
lished data) or caveolin-2 in FRT cells (Figure 1K) rapidly
redistributed from the LBs to the Golgi complex. Labeling
for caveolin-2 reappeared within the Golgi complex after 1 h
of removing the OlAc (arrows, Figure 1J). The recovery was
completed within 4 h (Figure 1K). The recovery of caveolin
occurred before there was any significant decrease in size or
number of LBs in the cells and before loss of staining for the
lipid body protein, adipophilin (unpublished data). There-
fore, caveolin-1 and -2 show rapid and reversible association
with LBs. These studies identify a bidirectional trafficking
pathway between LBs and the Golgi complex, which is
controlled by lipid loading of the cells.
Caveolins Associate with LBs in Regenerating Liver
The accumulation of LBs in the early stages of liver regen-
eration after partial hepatectomy (PH, removal of 66% of the
Figure 1. Caveolins traffic between LBs and the Golgi complex in response to lipid loading of the cells. (A–G) A431 cells were incubated
with or without 50 g/ml OlAc for 24 h and labeled with specific caveolin-1 (rbTL) and caveolin-2 (TLcav2) antibodies. In untreated A431
cells, caveolin was located on the plasma membrane and the Golgi complex (A). In contrast, caveolin-2 was accumulated in the Golgi complex
(B). Both caveolins showed a high degree of colocalization in the Golgi complex (arrows). In contrast, lipid loading caused redistribution of
caveolin-1 (C) and 2 (D) to ring-shaped cytoplasmic structures (arrowheads) identified as lipid bodies by Nile red staining (E–G). Some LBs
contained both caveolins (arrowheads). (H–N) FRT cells were incubated for 16 h with OlAc and labeled with specific anticaveolin-2 (TLcav2)
antibodies. In untreated cells, caveolin-2 was concentrated in the Golgi complex (H). In the presence of OlAc (I), caveolin-2 redistributed to
Nile red–positive lipid bodies (L–N). In addition, a loss of Golgi staining for caveolin-2 was apparent. When OlAc was washed out, caveolin-2
partially recovered its initial distribution in the Golgi complex after 1 h (arrows in J). The recovery was completed 4 h after of the washout
(K). Bars, 5 m.
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liver mass) has been well documented (Glende and Morgan,
1968; see also Figure 3). This offers an excellent physiological
system to examine formation and association of proteins
with LBs in vivo.
We first analyzed the distribution of caveolin in sucrose
density gradients of liver postnuclear supernatants. As
shown in Figure 2, A and B, there was a significant redistri-
bution of caveolin from the bottom of the gradient in control
livers to accumulate in a very low density fraction in regen-
erating liver 24 h after PH (26.86% of the total caveolin). To
gain insights into the redistribution of caveolin, we analyzed
the levels of caveolin-1 in different subcellular membrane
fractions isolated from control and regenerating rat liver.
After PH, there was a progressive increase in the levels of
caveolin in the homogenates (Figure 2C). In parallel, the
amount of caveolin-1 in a crude membrane fraction (com-
posed mainly of PM and ER membranes) increased at 24 h of
the regenerative process (from 5.6% of the total caveolin in
control liver to 26.6% 24 h after PH; Figure 2, D and F).
Interestingly, although the amount of caveolin associated
Figure 2. Caveolin associates with LBs
during rat liver regeneration. Biochemical
characterization. (A) Amount of protein and
distribution of caveolin in sucrose density
gradients of liver postnuclear supernatants.
Twenty-four hours after PH there is a sig-
nificant redistribution of caveolin to LBs
(top of the gradient, arrow). (B) Quantifica-
tion by densitometry of caveolin distribu-
tion (shown in A) in control or in livers 24 h
after PH. The results are expressed as the
level of caveolin in each lane relative to the
total intensity. Quantification was per-
formed from the data in the figure but sim-
ilar results were obtained in three indepen-
dent experiments. Twenty-four hours after
the partial hepatectomy 26.86% of the total
caveolin can be found in LBs (arrow). (C–E)
At different times after a partial hepatec-
tomy (PH), the amount of caveolin present
in liver homogenates and in different sub-
cellular fractions (RRC; recycling receptor
endosomes, CEF; caveolae-enriched plasma
membrane fraction, and PM/ER; crude
membrane fraction containing PM and ER
membranes) was compared by Western
blotting (rbTL). (C) Total levels of caveolin
in the liver increases after PH. (D) Caveolin
redistributes from the caveolae-enriched
fraction (CEF) to the crude membrane frac-
tion containing the ER and plasma mem-
brane. (E) An LB-enriched fraction was iso-
lated from control and regenerating livers
and the amount of caveolin-1 (rbTL) and -2
(TLcav2) analyzed by Western blot. While
the amount of caveolins in control livers
was relatively low, both caveolins accumu-
lated in the LB fraction 24 h after PH. At
later stages of regeneration (48 h) the levels
of caveolins in LBs decreased. (F) The redis-
tribution of caveolin in the purified mem-
brane fractions, described in D and E, was
quantified by densitometry as described
previously.
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with the endosomes of the receptor recycling compartment
(RRC; Pol et al., 1999) was not modified after PH, the levels
of caveolin in a caveolae-enriched plasma membrane frac-
tion (CEF) decreased significantly (from 58 to 11.3%; Figure
2, D and F) suggesting redistribution of the protein from the
PM to an intracellular compartment.
To investigate whether caveolin-1 and -2 associate with
LBs, we isolated LBs at different times of the regeneration
process by flotation in sucrose density gradients. LBs accu-
mulate at the top of the gradient due to their low density
(see MATERIALS AND METHODS for more details and see
Figure 4 for the characterization of the gradients). Figure 2D
shows that although the amount of caveolin-1 and -2 in the
LB fraction from control liver was low, both caveolins accu-
mulated in LBs 24 h after PH (29.5% of the total caveolin
accumulated in LBs; Figure 2, E and F). Interestingly, at later
stages of regeneration (48 h), when LBs are still abundant
(unpublished data), the levels of caveolins in this fraction
decreased dramatically, suggesting regulated redistribution
from the LBs.
We finally analyzed by means of microscopy techniques
the reorganization of caveolin in response to the regenera-
tion process. Figure 3, A and B, shows the high concentra-
tion of LBs in the cytosol of hepatocytes 24 h after PH. Next,
we studied the distribution of caveolin-1 (moTL) by immu-
nofluorescence microscopy on sections from control and
regenerating livers 24 h after PH. In control liver, caveolin
was almost exclusively associated with the PM, correspond-
ing to the sinusoidal region of hepatocytes (arrowheads,
Figure 3D). However, after 24 h of PH there was a clear
redistribution of caveolin to the LBs (arrowheads, Figure 3E)
and this could be confirmed by immunoelectron microscopy
Figure 3. Caveolin associates with LBs during rat liver regeneration. Microscopic characterization. Spur sections of control livers (A) and
livers 24 h after PH (B). The accumulation of LBs in the cytosol of the hepatocytes can be observed. (D–G) Sections of control (D and F) and
regenerating livers (E and G) were labeled with a mAb for caveolin-1 (moTL; D and E) and with a specific antibody to adipophilin (a marker
of LBs; F and G). After 24 h of PH caveolin relocated from the sinusoidal PM of the hepatocytes (arrows) to intracellular structures identified
as LBs by the presence of adipophilin. This was confirmed by immunogold electron microscopy on frozen sections using the rbTL antibody
(C). (H–K) Hepatocytes from control (H and J) or regenerating livers (I and K) were isolated and the distribution of caveolin analyzed with
a mAb for caveolin-1 (moTL; H and I) and for adipophilin (J and K). As in liver sections, 24 h after a PH caveolin-1 was detected decorating
the surface of intracellular LBs. Bars, (A and B) 2 m; (D) 200 nm; (E–L) 5 m.
Caveolin and Lipid Bodies
Vol. 15, January 2004 103
on ultrathin frozen sections (Figure 3C). The relocation of
caveolin-1 contrasted with the immunofluorescence pattern
of ASGP-R, a well-characterized plasma membrane receptor
located in clathrin-coated pits, which did not alter after PH
(unpublished data). Adipophilin, a marker of LBs, accumu-
lated in the LBs formed 24 h after PH (Figure 3G). We
further analyzed the relocation of caveolin during the regen-
eration process in isolated hepatocytes. As previously ob-
served in liver sections, and in contrast to control hepato-
cytes (Figure 3H), caveolin (moTL) decorated the surface of
spherical structures of the regenerating hepatocytes (Figure
3I), which were identified as LBs by labeling for adipophilin
(Figure 3K).
In summary, the distribution of caveolin in the hepatocyte
undergoes a significant change during the first hours of the
regeneration process. After 24 h of PH caveolin relocates
from the PM to intracellular LBs, suggesting a role for caveo-
lin in lipid homeostasis.
BFA Causes Redistribution of Caveolin to LBs: A Model
System to Follow Caveolin Accumulation in LB
It has been shown that heterologously expressed caveolin
can redistribute to LBs when the Golgi integrity is disrupted
by means of BFA and this offers an excellent model system
to further investigate trafficking of caveolin to and from LBs.
We studied the kinetics of association and the reversibility
of the redistribution of caveolin to LBs in BHK cells. As
shown by the con-cav antibody (an antibody that exclusively
recognizes the intracellular pool of caveolin (Figure 4A; Pol
et al., 2001) after 2 h with the drug caveolin accumulated in
the periphery of the rings identified as LBs (arrows, Figure
4B) by the presence of adipophilin (unpublished data). To
test the reversibility of the BFA effect on caveolin, the cells
were treated with BFA, and then the drug washed out,
allowing the cells to recover for 30 min. The recovery after
the washout was almost complete (Figure 4C).
To confirm the results obtained by immunofluorescence,
we further characterized by biochemical methods, the asso-
ciation of caveolin with purified LBs. To induce the forma-
tion of LBs the cells were also treated with OlAc as previ-
ously described in Figure 1. Then, control or OlAc-treated
BHK cells were treated with BFA, and the cell homogenates
were resolved on sucrose density gradients by ultracentrif-
ugation. In this gradient, ER, Golgi, and PM markers were
detected around 25% sucrose, and adipophilin was detected
around 5% sucrose (unpublished data). As expected, in un-
treated cells, caveolin (rbTL) accumulated in densities cor-
responding to the PM (25% sucrose, fraction 6–7) and little
(0.3% of the total caveolin) was detected at the density
corresponding to the LBs (5% sucrose, fraction 1; Figure 4D,
top panel). The enrichment of LBs and purity of this fraction
was confirmed by electron microscopy (see later in Figure
5A). When cells treated with BFA or with OlAc were re-
solved by the same method, a significant amount of caveolin
shifted to fraction 1 (Figure 4D, middle panel). The accumu-
lation of caveolin at the top of the gradient was maximal
(6.8% of the total caveolin) when cells preincubated in OlAc
were treated for 2 h with BFA (Figure 4D, bottom panel).
Note that although the amount of caveolin in top of the
gradient increases considerably (20-fold), it still represents
a low percentage of the total cellular caveolin.
To quantify the amount of caveolin present on LBs in
response to the different treatments, equal volumes of frac-
tion 1 were analyzed by Western blotting with the rbTL
antibody (Figure 4E) and quantified by densitometry. As
compared with control cells, 2.99 times more caveolin was
detected in the fraction 1 isolated from cells treated with
BFA, 4.99 times when the cells were treated with OlAc, and
15.14 times when cells preincubated in OlAc were treated
with BFA. The same protocol was used to monitor the time
course of the accumulation of caveolin in fraction 1 in re-
sponse to BFA. As shown previously by immunofluores-
cence, there was a peak of caveolin (2.98 times) in fraction 1
corresponding to cells treated for 2 h with the drug (Figure
4F, left panel). The amount of caveolin decreased at longer
times (1.63 times). However, when the cells were pretreated
with OlAc and then incubated with BFA, caveolin rapidly
accumulated on LBs (2.19 times after 1 h; Figure 4F, right
panel). In this case, the high levels of caveolin detected in
fraction 1 were prolonged even after 4 h of incubation (4.55
times). Finally, the cells were treated for 2 h with BFA and
then the drug washed out for different times. In accordance
with the immunofluorescence results, in control cells the
amount of caveolin in LBs returned to control levels 30 min
after the washout (Figure 4G, left panel) or close to control
levels 45 min after the washout in cells pretreated with OlAc
(Figure 4G, right panel).
Immunolabeling of fraction 1 by electron microscopy con-
firmed the association of caveolin with the LBs and allowed
quantitation of the level of caveolin per LBs. Analysis of
fractions from OlAc-treated cells, OlAc/BFA-treated cells
(Figure 5C), or OlAc/BFA-treated cells allowed to recover
for 30 min (Figure 5D) showed 42 (27), 152 (106; how-
ever, with 80% of the LBs ranging from 95 to 222), and 42
(31) gold particles, respectively. In addition, the OlAc-
treated cells were processed for frozen sectioning and im-
munolabeled with anti–con-cav antibodies. Specific labeling
was associated with electron lucent LBs (Figure 5B).
Therefore, the treatment with BFA offers an excellent in
vitro model to induce a rapid but reversible association of
caveolins with LBs. This system can now be used to study
the mechanisms involved in the recruitment of membrane
proteins to these organelles. The results obtained in lipid
loaded cells also confirm that the steady state levels of
caveolin in this organelle are modulated by the lipid content
or size of the LBs.
A Caveolin Dominant Negative Mutant Affects LB
Motility and Lipid Redistribution
Caveolin-3 DGV (cavDGV) has been shown to perturb
plasma membrane lipid raft domains through an indirect
effect on cellular cholesterol. The mutant protein accumu-
lates irreversibly on LBs and causes increased accumulation
of neutral lipids in this organelle, while decreasing plasma
membrane free cholesterol. We investigated the effect of the
irreversible association of the cavDGV protein on the forma-
tion of LBs and on their properties.
LBs have been shown to undergo microtubule-dependent
motility. The dynamic behavior of LBs was monitored by
time-lapse video microscopy. LBs were stained with Nile
red and then followed by bright field microscopy for 3 min.
LBs showed bidirectional saltatory movements (see 3 repre-
sentative trajectories in Figure 6A, and complete movie in
supplementary material), which although far less extensive
than those observed in the same cells for late endosomes, are
completely blocked by incubation with nocodazole (unpub-
lished data). In striking contrast, transfection with cavDGV-
YFP caused an almost complete block in LB motility (see
yellow arrows in Figure 6A) compared with cells expressing
cav-3-YFP (0.2  0.07 vs. 1.1  0.2 m/s). Thus one effect of
cavDGV is to decrease LB motility.
One possibility to explain the inhibitory effects of cavDGV
is that the mutant is affecting the correct formation of LB, or,
alternatively, that cavDGV can form aberrant LBs indepen-
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dently of the presence of lipids. Therefore cavDGV-YFP was
transfected into serum-starved cells that lack LBs as defined
by Nile red staining and by bright field microscopy. In
contrast to full-length caveolin (unpublished data), cavDGV
localized to an extensive reticular compartment identifiable
as the ER with no punctate labeling evident (Figure 6B, time
0). Addition of OlAc to the starved cells caused an extremely
rapid formation of distinct puncta, putative forming LBs,
within minutes (Figure 6B, and complete movie in supple-
mentary material). At high magnification can be observed
that cavDGV accumulates in the periphery of the forming LBs
(unpublished data). Thus OlAc addition causes cavDGV to
Figure 4. BFA causes redistribution of caveolin to LBs; a model system to follow caveolin accumulation in LB. (A–C) Control BHK cells were
treated for 2 h with 5 g/ml BFA. Caveolin distribution was analyzed with the con-cav antibody (red channel) in combination with GM130
(a Golgi marker, green channel) and DAPI (nuclei, blue). Caveolin is detected in LBs (arrows in B). When, after 2 h with BFA, the drug is
washed out for 30 min, the recovery is almost complete (arrows C). (D–G) Untreated or OlAc-treated BHK cells were incubated for 2 h with
5 g/ml BFA and then resolved on sucrose density gradients. (D) In control cells caveolin (rbTL) accumulates in densities corresponding to
the PM (fraction 6–7, 20% sucrose; top). Caveolin partially shifts to the top of the gradient (fraction 1) when the cells are preincubated with
50 g/ml OlAc or treated for 2 h with BFA (middle). The accumulation in the top of the gradient is maximal (6.8%) when cells pretreated
with OlAc are incubated with BFA (bottom). Quantification, as described for Figure 2B, was performed from the data in the figure but similar
results were obtained in three independent experiments. (E) The LB fraction (1) for each treatment were isolated in parallel and equal volumes
resolved by Western blotting. The levels of caveolin after the different treatments (shown in the histograms) was quantified by densitometry
and it is indicated as relative to the first lane. (F) Using the same method, we compared the amount of caveolin in fraction 1 corresponding
to the gradients from cells treated for different times with BFA, in either 10%SS (left panel) or OlAc-pretreated cells (right panel). In control
cells caveolin reaches a peak after 2 h with the drug; however, in OlAc-treated cells high levels of caveolin are sustained after 4 h with BFA.
(G) BHK cells were treated for 2 h with BFA and then the drug was washed out for different times. In fraction 1 of control (left panel) or in
cells pretreated with OlAc (right panel), the levels of caveolin return to the initial levels after 30 or 45 min, respectively.
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redistribute from its diffuse distribution within the ER to
distinct sites involved in LB formation. CavDGV can there-
fore be used as a marker to follow LB biogenesis, and these
experiments illustrate the extremely rapid dynamics of LB
formation.
Previous studies showed that cavDGV expression increases
neutral lipid accumulation in LBs (Pol et al., 2001). Although
the intracellular accumulation of lipids induced by cavDGV
was variable, the mean increase in oil red staining in
cavDGV-transfected cells was more than twofold higher
than nontransfected cells (pixel intensity cavDGV-trans-
fected/untransfected cells 2.70/1.23; Figure 7E). To examine
the effect of cavDGV expression in detail, we next investi-
gated whether OlAc, which diffuses into the cell bypassing
the endosomal system, is accumulated more rapidly in LBs
in cavDGV-expressing cells. At early times (2 h) of OlAc
addition we observed no significant differences in neutral
lipid staining of cavDGV-transfected cells compared with
untransfected cells (unpublished data). After an incubation
of 16 h with OlAc, all the cells contained characteristic
enlarged LBs (pixel intensity: 6.25/5.72; compare Figure 7A
with Figure 7B). We then investigated whether cavDGV ex-
pression affected the handling of accumulated neutral lipids
after removal of OlAc from the culture medium. Untrans-
fected cells showed a progressive reduction in neutral lipid
staining upon removal of OlAc. However, there was a sig-
nificant delay in the loss of neutral lipid staining in the
cavDGV-expressing cells (Figure 7C; pixel intensity: 5.29/
2.25). Although LBs of untransfected cells became smaller,
the LBs containing cavDGV maintained their original size.
The differences were more obvious 24 h after the washout,
when only the cavDGV cells contained the enlarged LBs
(compare Figure 7A with Figure 7D; pixel intensity: 5.41/
1.36). Thus the cavDGV mutant has an inhibitory effect on the
catabolism/redistribution of lipids out of lipid bodies.
In conclusion, we have shown that the cavDGV mutant
associates rapidly with LBs upon OlAc treatment of cells
and we have revealed a striking effect of the mutant protein
on LB motility and lipid catabolism/redistribution.
DISCUSSION
This study shows for the first time that caveolins can asso-
ciate with LBs in vivo. We now show that endogenous
caveolin is detectable on LBs, that the association of caveolin
with LBs can be modulated, and most importantly that
caveolins cannot only enter but also exit LBs by as yet
unknown mechanisms. Moreover, in a physiologically rele-
vant in vivo setting, caveolins have been demonstrated to
associate with LBs, with a striking redistribution of caveo-
lins to LBs in regenerating liver. By using a caveolin domi-
Figure 5. BFA causes redistribution of caveolin to LBs; microscopic characterization. (B) OlAc-treated cells were processed for frozen
sectioning and immunolabeled with anti–con-cav antibodies. Specific labeling is associated with electron lucent LBs. (A, C, and D) Fraction
1 was applied to an EM grid and immunolabeled (without sectioning). (A) A low-magnification overview demonstrating the purity of the
fraction. (C and D) Immunolabeling with the con-cav antibody of fraction 1 from OlAc and BFA-treated cells (C) and the cells after 30 min
of recovery (D). Bars, 200 nm.
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nant negative mutant (cavDGV) we have been able to observe
the remarkably rapid dynamics of LB formation. The caveo-
lin mutant associates with LBs, causes irreversible accumu-
lation of lipids, and inhibits their microtubule-dependent
motility.
Lipid Bodies and Caveolin
The classical model for LB formation involves accumulation
of lipids between the lumenal and cytoplasmic leaflets of the
ER. The LBs, comprising a core of triglycerides and/or cho-
lesterol esters, are enclosed by a single monolayer (Tauchi-
Sato et al., 2002). LBs are then proposed to bud away from
the ER to generate free vesicles. However, a number of
studies have shown that ER membranes remain in close
association with the LBs (Novikoff et al., 1980; Prattes et al.,
2000; Pol et al., 2001). Rather than simply serving a storage
function, a number of observations suggest a more complex
role for LBs in cellular function. Signaling and trafficking
proteins have been observed on the surface of lipid bodies
(Yu et al., 1998, 2000; Wolins et al., 2001) but also see Barbero
et al., 2001, and the number of lipid bodies varies during the
cell cycle (Gocze and Freeman, 1994).
We have previously shown that cavDGV, a N-terminal
truncation of cav-3, associates irreversibly to LBs and in-
duces an intracellular cholesterol imbalance (Pol et al., 2001).
Because the inhibitory effects of this mutant are overcome by
expression of wild-type caveolins, this raises the possibility
that LBs could be part of the normal itinerary of caveolin in
Figure 6. A caveolin dominant negative mutant affects LB motility. (A) CavDGV-GFP transfected cells were incubated in a media containing
a marker for LBs, Nile red. Vero cells expressing cavDGV-GFP were selected under the microscope and then observed in the Nile red channel.
The field shows two cavDGV-GFP–expressing cells (asterisks) and one untransfected cell. Images with a delay of 10 s were captured over 3
min. The figure shows a selected sequence of nine consecutive frames (20-s interval between images) representing a total period of 180 s. Nile
red–labeled vesicles showed a rapid bidirectional saltatory movement (red, green, and blue arrows for the position in each frame or color
lanes for the total trajectory). However, cavDGV vesicles showed no significant motility in any axis (yellow arrows; see histogram). (B) In an
attempt to study the formation of LBs containing the mutant protein, starved cells were transfected with cavDGV-GFP for 24 h and then
observed by videomicroscopy. CavDGV accumulated in an extensive reticular compartment identified as ER (first panel, time 0). OlAc was
then added to the medium and images were captured with a constant interval of 10 s (focus was maintained at the same level). The figure
shows a selected sequence of six consecutive frames representing a total period of 10 min. All the frames were processed equally and finally
the image was photographically inverted to increase the contrast. In response to the lipid loading of the cell, cavDGV progressively
redistributes from the tubules of the ER to the forming droplets visible as distinct dots.
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the cell. These studies prompted us to investigate the asso-
ciation of endogenous caveolin with LBs in cultured cells
and in an in vivo situation, first as a model system to
understand association of a membrane protein with LBs and
second to examine whether caveolins in LBs may have some
physiological role.
Taken together our results suggest that under normal
culture conditions there is a relatively small pool of caveolin
Figure 7. A caveolin dominant negative mutant inhibits lipid redistribution. (A) CavDGV-GFP was transfected in BHK cells for 24 h, the cells
were fixed in PFA and stained with oil red. CavDGV induced the accumulation of LBs, but few droplets could be detected in nontransfected
cells (see the profile of the cells). (B) CavDGV-GFP was transfected in BHK cells for 16 h in a medium containing OlAc. Transfected and
nontransfected cells showed the accumulation of the enlarged LBs and no differences could be observed in the uptake of lipids or in the size
of the droplets. (C and D) BHK cells treated as in B were incubated in a new media without OlAc. After 12 h of recovery, the LBs of
nontransfected cells were greatly reduced in size. The presence of cavDGV inhibited the decrease in size of the LBs and this was more apparent
after 24 h. As in control cells, no LBs were observed in nontransfected cells (see profile of the cell, compare with A). In striking contrast, the
OlAc induced droplets of the cavDGV cells were not able to recover and kept the original size (compare D and A). Bars, 5 m. (E) The
histogram shows the quantification of the oil red–associated fluorescence in nontransfected vs. DGV transfected cells after the treatments
described in A–D.
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associated with LBs, as judged by both biochemistry and
immunofluorescence. However, in lipid-loaded cells there is
a significant pool of endogenous caveolin-1 and caveolin-2
associated with LBs. This was most clearly demonstrated in
FRT cells, where caveolin-2 showed oleic acid-induced
translocation from the Golgi complex to LBs. Importantly,
when oleic acid was removed from the culture medium,
caveolin-2 redistributed back to the Golgi complex even
though abundant enlarged LBs were still evident in the cells.
This suggests that caveolin is not simply redistributed to LBs
as a consequence of the formation of abundant enlarged LBs
but that the trafficking of caveolin is regulated. It remains to
be seen whether the reported fatty acid binding properties of
caveolin (Trigatti et al., 1999) could be involved in this pro-
cess. Other proteins are known to be targeted to LBs upon
oleic acid treatment including Nir2, the mammalian homo-
logue of the Drosophila protein RdgB, which is associated
with retinal degeneration (Litvak et al., 2002). Similarly to
cavDGV, it has been suggested that disruption of lipid regu-
lation by the LB-associated mutant protein might affect
membrane biogenesis required for photoreceptor mainte-
nance (Litvak et al., 2002).
The long hydrophobic putative intramembrane domain of
caveolin could mediate the interaction with the hydrophobic
core of the LBs (Fujimoto et al., 2001; Ostermeyer et al., 2001).
Previous studies have shown that caveolin can be cross-
linked to gangliosides inserted into the extracellular leaflet
of the plasma membrane (Fra et al., 1995), consistent with the
caveolin molecule protruding through the cytoplasmic leaf-
let of the LB and into the core. This model explains why
caveolin, which has been compared with plant LB-associ-
ated oleosins (Brown, 2001), can associate with lipid bodies
within the ER, as diffusion in the plane of the membrane
would allow the preferential association of caveolin with the
lipid body. However, it is much more difficult to explain the
intriguing observations presented here ,which demonstrate
convincingly that caveolin can exit the LB upon washout of
lipids or BFA. One possibility is that mechanisms exist to
decrease the affinity of caveolin for the LB core. Alterna-
tively, interactions with other proteins might move caveo-
lins away from the LBs, allowing their recruitment into
forming transport vesicles in the ER. Both these possibilities
require the LBs containing caveolin to remain ER-attached.
However, LBs are generally considered to bud from the ER,
and this would suggest the existence of trafficking pathways
from the LBs or interactions with other organelles to explain
the retrieval of caveolin from the LBs.
A Caveolin Dominant Negative Mutant Decreases LB
Motility and Causes Lipid Retention in LBs
The reversible association of caveolins with LBs strengthens
the hypothesis that caveolins could play some physiological
role in lipid regulation. We now show that the mutant
cavDGV causes a dramatic decrease in the microtubule-de-
pendent motility of LBs. Previous studies have shown that
LBs exhibit bidirectional movement on microtubules and
this is inhibited by disruption of the dynactin complex (Val-
etti et al., 1999). Our studies now demonstrate that this
movement can be modulated by association of the cavDGV
mutant. Interestingly, the mutant causes free cholesterol
accumulation in late endosomes and this also inhibits late
endosomal motility (Pol et al., 2001), consistent with earlier
studies showing Rab7-dependent motility regulation by
cholesterol (Lebrand et al., 2002). Second, and consistent
with previous observations (Pol et al., 2001), we have shown
that the cavDGV mutant alters neutral lipid accumulation in
LBs, primarily through inhibition of neutral lipid removal
from the LB stores after lipid accumulation. Accumulation of
oleic acid, which is believed to diffuse across the plasma
membrane and through the cytoplasm to forming LBs, is not
significantly altered by the cavDGV mutant. Whether the
effects on LB motility and lipid removal from LBs is con-
nected remains to be seen, but it is tempting to speculate that
LB motility may facilitate movement of lipids to intracellular
sites where they are required. Loss of LB motility may also
contribute to the observed accumulation of free cholesterol
in late endosomes. The cavDGV mutant is an excellent tool to
provide new insights into these processes. The results of this
and our previous study (Pol et al., 2001) suggest a link
between the LB association of the mutant caveolin and levels
of surface cholesterol as revealed by filipin staining and by
functional signaling assays. In view of the complex interre-
lationships between the cholesterol levels in different intra-
cellular pools it is possible that surface cholesterol levels are
dependent on rates of esterification/hydrolysis in LBs. In
adipocytes, removal of surface cholesterol with cyclodextrin
caused mobilization of cholesterol from cholesterol ester
stores in the LBs and redistribution of free cholesterol to
efflux sites at the PM, suggesting an efflux pathway from LBs
to the PM (Prattes et al., 2000). Both pharmacological inhibi-
tion of cholesterol esterification and treatment of cells with
free fatty acids has been shown to cause changes in surface
free cholesterol levels (Seo et al., 2002). Taken together with
the results presented here, these studies suggest that LBs
play a hitherto unexplored role in maintenance of surface
cholesterol levels.
The cavDGV mutant has also allowed us to study the
formation of LBs in real time. In serum-starved cells that
lack detectable LBs, the cavDGV mutant accumulates in the
ER. On addition of oleic acid, LBs form rapidly at discrete
sites within the ER, which are spread throughout the cyto-
plasm. On oleic acid addition, the cavDGV mutant is imme-
diately recruited to these domains. These studies demon-
strate the incredible dynamic nature of LB but also raises the
question of why LBs form in specific regions of the ER. It
was shown recently that the LB phospholipid composition is
quite distinct to the ER, suggesting that LBs form at specific
sites (Tauchi-Sato et al., 2002). This provides an excellent
model system to understand the exact molecular require-
ments for LB formation.
Caveolin Association with LBs in Regenerating Liver
Further support for the contention that the association of
caveolin with LBs has physiological significance come from
the findings presented here demonstrating the association of
caveolin with LBs in regenerating liver After PH, there is a
hormone-dependent mobilization of fat from adipose tissue
(Glende and Morgan, 1968). Plasma free fatty acid levels
(i.e., oleic, palmitic, palmitoleic, and linoleic acids) are five
times normal levels 12–18 h after PH. As a result, the levels
of hepatic cholesterol and triglycerides increase 10-fold after
18–24 h (Glende and Morgan, 1968). The steatotic (fat) liver
is a paradigm, with several diseases in which the accumu-
lation of fat in the hepatocytes has been well characterized
(early stages of cirrhosis, alcoholic liver or in nonalcoholic
steatotic syndromes; Koteish and Diehl, 2001).
Interestingly, during this process caveolin relocates
from the PM to accumulate on LBs presumably as part of
the lipid mobilization process. The reduction of caveolin/
caveolae at the plasma membrane may correlate with the
general arrest of endocytosis and membrane trafficking,
cause a change in signaling, or is a response to the
changed lipid requirements of the tissue. Caveolin has
been described as a key regulator of the efflux of cellular
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cholesterol. It is possible that decreasing the rate of trans-
port of caveolin to the PM and redirecting the protein to
a different compartment may result in the intracellular
accumulation of cholesterol. This new pool of cholesterol
could then be used for the synthesis of new membranes.
Further studies are necessary to test the role that caveolin
plays in the “adapted” lipid metabolism that occurs in
regenerating liver. However, this is an intriguing obser-
vation that further supports the role of caveolin, now in
vivo, in the intracellular homeostasis of lipids and pro-
vides new insights into the study of caveolins and LB
function.
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